{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:42:13Z","timestamp":1770133333252,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.amjmed.2006.03.029","type":"journal-article","created":{"date-parts":[[2007,3,8]],"date-time":"2007-03-08T07:02:06Z","timestamp":1173337326000},"page":"251-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Gaps in Treatment Among Users of Osteoporosis Medications: The Dynamics of Noncompliance"],"prefix":"10.1016","volume":"120","author":[{"given":"M. Alan","family":"Brookhart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Avorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey N.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel S.","family":"Finkelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"Polinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda R.","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Mogun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel H.","family":"Solmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2006.03.029_bib1","series-title":"Compliance in Health Care","author":"Haynes","year":"1979"},{"key":"10.1016\/j.amjmed.2006.03.029_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2006.03.029_bib3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hec.609","article-title":"The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature","volume":"10","author":"Hughes","year":"2001","journal-title":"Health Econ"},{"key":"10.1016\/j.amjmed.2006.03.029_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.282.4.313","article-title":"Noncompliance may cause half of antihypertensive drug \u201cfailures\u201d","volume":"282","author":"Stephenson","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2006.03.029_bib5","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1001\/jama.288.22.2868","article-title":"Interventions to enhance patient adherence to medication prescriptions: scientific review","volume":"288","author":"McDonald","year":"2002","journal-title":"JAMA"},{"key":"#cr-split#-10.1016\/j.amjmed.2006.03.029_bib6.1","unstructured":"Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications [update of Cochrane Database Syst Rev. 2000(2):CD000011"},{"key":"#cr-split#-10.1016\/j.amjmed.2006.03.029_bib6.2","unstructured":"PMID: 10796686]. Cochrane Database Syst Rev. 2002(2):CD000011."},{"key":"10.1016\/j.amjmed.2006.03.029_bib7","series-title":"Adherence to long-term therapies: evidence for action. World Health Organization [Web report]","author":"Sabate","year":"2005"},{"key":"10.1016\/j.amjmed.2006.03.029_bib8","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/archinte.165.20.2414","article-title":"Compliance with osteoporosis medications","volume":"165","author":"Solomon","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2006.03.029_bib9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1210\/jc.2003-030501","article-title":"The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial","volume":"89","author":"Clowes","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjmed.2006.03.029_bib10","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1525-1497.2004.30516.x","article-title":"Suboptimal statin adherence and discontinuation in primary and secondary prevention populations","volume":"19","author":"Ellis","year":"2004","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.amjmed.2006.03.029_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2125.2003.01818.x","article-title":"Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristics","volume":"56","author":"Yang","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.amjmed.2006.03.029_bib12","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1001\/archinte.164.21.2343","article-title":"Impact of concurrent medication use on statin adherence and refill persistence","volume":"164","author":"Grant","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2006.03.029_bib13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.288.4.455","article-title":"Long-term persistence in use of statin therapy in elderly patients [see comment]","volume":"288","author":"Benner","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2006.03.029_bib14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/archinte.165.10.1147","article-title":"Predictors of adherence with antihypertensive and lipid-lowering therapy","volume":"165","author":"Chapman","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2006.03.029_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1067\/mcp.2000.105582","article-title":"Erratic patient compliance with prescribed drug regimens: target for drug delivery systems","volume":"67","author":"Urquhart","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2006.03.029_bib16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00003088-199732050-00001","article-title":"The electronic medication event monitor","volume":"32","author":"Urquhart","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.amjmed.2006.03.029_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.amjmed.2006.03.029_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and lifetables","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B"},{"key":"10.1016\/j.amjmed.2006.03.029_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/oxfordjournals.aje.a115853","article-title":"The case-crossover design: a method for studying transient effects on the risk of acute events","volume":"133","author":"Maclure","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.amjmed.2006.03.029_bib20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.annepidem.2003.09.012","article-title":"Use of the case-crossover design to study prolonged drug exposures and insidious outcomes","volume":"14","author":"Wang","year":"2004","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.amjmed.2006.03.029_bib21","unstructured":"SAS, Version 9.1 [computer program]. Cary, NC: SAS Institute Inc.; 2003."},{"key":"10.1016\/j.amjmed.2006.03.029_bib22","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1532-5415.2005.53401.x","article-title":"Differing patterns of antiresorptive pharmacotherapy in nursing facility residents and community dwellers","volume":"53","author":"Jachna","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjmed.2006.03.029_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1525-8610(04)70346-1","article-title":"Underuse of procedures for diagnosing osteoporosis and of therapies for osteoporosis in older nursing home residents","volume":"4","author":"Gupta","year":"2003","journal-title":"J Am Med Dir Assoc"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934306005067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934306005067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:44:41Z","timestamp":1757580281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934306005067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0002934306005067"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2006.03.029","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gaps in Treatment Among Users of Osteoporosis Medications: The Dynamics of Noncompliance","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2006.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}